US Broker Ratings

CVS Health Corporation (CVS) Stock Analysis: A Healthcare Giant with a 9.25% Potential Upside

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, offers a fascinating investment opportunity, especially for those interested in healthcare plans and services. With a market capitalization of..

Cardinal Health, Inc. (CAH) Stock Analysis: Unveiling a 22% Upside Potential in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 22.22%. With a robust market capitalization of $47 billion,..

Waters Corporation (WAT) Stock Analysis: Analyst Ratings Signal 16.99% Upside Potential

Waters Corporation (NYSE: WAT), a notable player in the healthcare sector, is making waves in the diagnostics and research industry. With a market capitalization of $33.62 billion, this U.S.-based company..

Humana Inc. (HUM) Stock Analysis: Navigating Healthcare Growth with Caution Amidst Valuation Concerns

Humana Inc. (NYSE: HUM), a leading player in the healthcare plans sector, represents a significant entity in the United States healthcare market. With a market capitalization of approximately $36.97 billion,..

STERIS plc (STE) Stock Analysis: Unveiling a Promising 18.60% Upside Potential

Investors with an eye on the healthcare sector have much to consider with STERIS plc (NYSE: STE), a prominent player in the medical devices industry. As a company specializing in..

DexCom, Inc. (DXCM) Stock Analysis: Strong Buy Ratings Signal Potential Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector with a focus on medical devices, has been making significant strides in the continuous glucose monitoring (CGM) market. Headquartered in..

IQVIA Holdings, Inc. (IQV): Analyst Consensus Reveals 36% Upside Potential for Healthcare Giant

Investors with an eye on the healthcare sector should consider the promising outlook for IQVIA Holdings, Inc. (NYSE: IQV), a leader in the diagnostics and research industry. With a substantial..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30.72% Upside Potential Beckons Healthcare Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG) has long been a trailblazer in the healthcare sector, especially within the niche of minimally invasive surgical systems. With its flagship da Vinci Surgical System,..

Boston Scientific Corporation (BSX) Stock Analysis: 44% Potential Upside Signals Promising Investment Opportunity

For investors eyeing opportunities in the healthcare sector, Boston Scientific Corporation (NYSE: BSX) stands out with its robust market presence and promising potential upside. With a market capitalization of $85.88..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring Growth Potential Amid Robust Revenue Gains

Investors eyeing opportunities in the healthcare sector should pay close attention to Novo Nordisk A/S (NVO), a Danish pharmaceutical giant with a commanding presence in diabetes and obesity care. With..

Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Giant’s 5.99% Upside Potential Captivates Investors

Merck & Company, Inc. (NYSE: MRK) stands as a formidable name in the global healthcare sector, showcasing a robust market capitalization of $302.33 billion. As one of the prominent players..

Regeneron Pharmaceuticals, Inc. (REGN): Analyst Ratings Signal Strong Buy with 30% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a titan in the biotechnology industry, has been capturing the attention of investors with a promising 30.43% potential upside. With its current price at $638.88,..

ResMed Inc. (RMD) Stock Analysis: Robust Growth Potential Amidst Healthcare Innovations

ResMed Inc. (NYSE: RMD), a leader in the healthcare sector, has been making significant strides in the medical instruments and supplies industry. With a market capitalization of $30.18 billion, ResMed..

McKesson Corporation (MCK) Stock Analysis: Exploring a 23.97% Potential Upside and Solid Growth Prospects

Investors looking to diversify their portfolios with a robust player in the healthcare sector might find McKesson Corporation (NYSE: MCK) a compelling choice. With a commanding market capitalization of $92.09..

Novartis AG (NVS) Stock Analysis: Strong ROE and Strategic Focus Positioning for Growth

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, specifically within the drug manufacturing industry, has once again caught the eye of investors with its robust financial metrics..

AbbVie Inc. (ABBV) Stock Analysis: Unraveling a 17% Potential Upside Amid Robust Buy Ratings

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector specializing in drug manufacturing, has captured investor attention with a notable 17.24% potential upside. The biopharmaceutical giant, with a market..

Inspire Medical Systems, Inc. (INSP): Investor Outlook Highlights 33% Potential Upside

Inspire Medical Systems, Inc. (NYSE: INSP) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Golden Valley, Minnesota, Inspire Medical has carved out..

Corcept Therapeutics Inc. (CORT) Stock Analysis: Exploring a 40.15% Potential Upside for Biotech Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) is attracting attention from investors with its focus on developing innovative treatments for severe endocrinologic, oncologic, metabolic, and neurologic disorders. With a market capitalization of..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a Promising 103% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology sector, is gaining attention for its innovative approach to developing therapeutic and diagnostic radiopharmaceuticals. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy with 10.83% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a notable player within the healthcare sector, specifically in the niche of specialty and generic drug manufacturing. With a market capitalization of $6.11..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds